Poly(ε-caprolactone) microcapsules and nanocapsules in drug delivery

Expert Opinion on Drug Delivery

Volumn 10, Issue 5, 2013, Pages 623-638

  Pohlmann, Adriana Raffin ^a   Fonseca, Francisco Noe ^a   Paese, Karina ^a   Detoni, Cassia Britto ^a   Coradini, Karine ^a   Beck, Ruy CR ^a   Guterres, Silvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Drug delivery systems; Lipid core nanocapsules; Microcapsules; Nanocapsules; Poly( caprolactone); Polymer

Indexed keywords

4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; BOVINE SERUM ALBUMIN; CLOBETASOL; DEXAMETHASONE; DICLOFENAC; EUDRAGIT RS; INDOMETACIN; LIPID; LIPOSOME; NANOCAPSULE; NANOSPHERE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OIL; PANTOPRAZOLE; POLYCAPROLACTONE; POLYMER; RESVERATROL; SURFACTANT; TOCOPHEROL; TULOBUTEROL;

CHANNEL GATING; COMMERCIAL PHENOMENA; CONTROLLED DRUG RELEASE; DIGESTIVE SYSTEM INJURY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; DRUG TISSUE LEVEL; GRANULOMA; HUMAN; MICROCAPSULE; MICROENCAPSULATION; NANOEMULSION; NANOENCAPSULATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PAW EDEMA; POLYMERIZATION; REVIEW; SCALE UP; SKIN PENETRATION; SKIN PERMEABILITY; SOLID; TARGET ORGAN; TISSUE DISTRIBUTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; NANOCAPSULES; POLYESTERS; POLYMERS; SKIN; SOLUBILITY; SUNSCREENING AGENTS;

EID: 84876548672     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.769956     Document Type: Review

References (100)

1. Labet M, Thielemans W. Synthesis of polycaprolactone: A review. Chem Soc Rev 2009;38:3484-504
2. Kim KS, Park SJ. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol. Colloids Surf B Biointerfaces 2010;76:404-9
3. Park SJ, Lee YM, Hong SK. Release behaviors of porous poly(butylene succinate)/poly(e-caprolactone) microcapsules containing indomethacin. Colloids Surf B Biointerfaces 2006;47:211-15
4. Youan BBC, Jackson TL, Dickens L, et al. Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Release 2001;76:313-16
5. Raffin RP, Colomé LM, Guterres SS, et al. Enteric controlled-release pantoprazole-loaded microparticles prepared by using Eudragit S100 and poly(e-caprolactone) blend. Pharm Dev Technol 2007;12:463-71 (Pubitemid 350034880)
6. Sinha VR, Bansal K, Kaushik R, et al. Poly-e-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004;278:1-23
7. Wei X, Gong C, Gou M, et al. Biodegradable poly(e-caprolactone)-poly (ethylene glycol) copolymers as drug delivery system. Int J Pharm 2009;381:1-18
8. Kumari A, Yadav SK, Yadav SC. Biodegrable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010;75:1-18
9. Woodruff MA, Hutmacher DW. The return of a forgotten polymer- polycaprolactone in the 21st century. Prog Polym Sci 2010;35:1217-56
10. Gou M, Wei X, Men K, et al. PCL/PEG Copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets 2011;12(8):1131-50
11. Dash TK, Konkimalla VB. Poly-ecaprolactone based formulations for drug delivery and tissue engineering: A review. J Control Release 2012;158:15-33
12. Wang Y, Gou M, Gong C, et al. Pharmacokinetics and disposition of nanomedicine using biodegradable PEG/PCL polymers as drug carriers. Curr Drug Metab 2012;13(4):338-53
13. Lensen D, Vriezema DM, van Hest JCM. Polymeric microcapsules for synthetic applications. Macromol Biosci 2008;8:991-1005
14. Park SJ, Yang YJ, Lee HB. Effect of acid-base interaction between silica and fragrant oil in the PCL/PEG microcapsules. Colloids Surf B Biointerfaces 2004;38:35-40
15. Poletto FS, Jager E, Ré MI, et al. Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs. Int J Pharm 2007;345:70-80 (Pubitemid 350087543)
16. Oh A, Yun J, Kim I. Controlled release behavior of PCL/PEO/activated carbon composite microcapsule. J Polym Res 2011;18:2441-7
17. Lionzo MIZ, Ré MI, Guterres SS, et al. Microparticles prepared with poly (hydroxybutyrate-co-hydroxyvalerate) and poly(e-caprolactone) blends to control the release of a drug model. J Microencapsul 2007;24(2):175-86 (Pubitemid 46502159)
18. Park SJ, Kim KS. Effect of oxygen plasma treatment on the release behaviors of poly(e-caprolactone) microcapsules containing tocopherol. Colloids Surf B Biointerfaces 2005;43:138-42
19. Coccoli V, Luciani A, Orsi S, et al. Engineering of poly(e-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J Mater Sci Mater Med 2008;19:1703-11 (Pubitemid 351388893)
20. Wu H, Liao C, Jiao Q, et al. Fabrication of core-shell microspheres using alginate and chitosan-polycaprolactone for controlled release of vascular endothelial growth factor. React Funct Polym 2012;72:427-37
21. Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm 2008;364:328-43
22. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010;385:113-42
23. Fessi H, Puisieux F, Devissaguet JP, et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989;55:R1-4 (Pubitemid 19247505)
24. Quintanar-Guerrero D, Alle'mann E, Doelker E, et al. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharm Res 1998;15(7):1056-62 (Pubitemid 28356923)
25. Mora-Huertas CE, Garrigues O, Fessi H, et al. Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: Comparative study. Eur J Pharm Biopharm 2012;80:235-9
26. Alvarez-Roma'n R, Barré G, Guy RH, et al. Biodegradablepolymer polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 2001;52:191-5 (Pubitemid 32755898)
27. Alvarez-Roma'n R, Naik A, Kalia YN, et al. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004;21:1818-25 (Pubitemid 39390094)
28. Abdelwahed W, Degobert G, Fessi H. A pilot study of freeze drying of poly (epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization. Int J Pharm 2006;309:178-88 (Pubitemid 43129481)
29. Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm 2006;63:87-94 (Pubitemid 43776204)
30. Bender EA, Adorne MD, Colomé LM, et al. Hemocompatibility of poly(ecaprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int J Pharm 2012;426:271-9
31. Calvo P, Thomas C, Alonso MJ, et al. Study of the mechanism of interaction of poly(e-caprolactone) nanocapsules with the cornea confocal laser scanning microscopy. Int J Pharm 1994;103:283-91
32. Calvo P, Sa'nchez A, Marti'nez J, et al. Polyester nanocapsules as new topical ocular delivery systems for Cyclosporin A. Pharm Res 1996;13(2):311-15 (Pubitemid 26074197)
33. Calvo P, Vila-Jato JL, Alonso MJ. Effect of lysozyme on the stability of polyester nanocapsules and nanoparticles: Stabilization approaches. Biomaterials 1997;18:1305-10 (Pubitemid 27406136)
34. Campos AM, Sanchez A, Gref R, et al. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003;20:73-81 (Pubitemid 37103234)
35. Lboutounne H, Chaulet JF, Ploton C, et al. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(ecaprolactone) nanocapsules encapsulated form and as a digluconate. J Control Release 2002;82:319-34 (Pubitemid 34880187)
36. Tewa-Tagne P, Briançon S, Fessi H. Spray-dried microparticles containing polymeric nanocapsules: Formulation aspects, liquid phase interactions and particles characteristics. Int J Pharm 2006;325:63-74 (Pubitemid 44573696)
37. Tewa-Tagnea P, Briançon S, Fessi H. Preparation of redispersible dry nanocapsules by means of spray-drying: Development and characterization. Eur J Pharm Sci 2007;30:124-35 (Pubitemid 46157175)
38. Weiss-Angeli V, Bourgeois S, Pelletier J, et al. Development of an original method to study drug release from polymeric nanocapsules in the skin. J Pharm Pharmacol 2010;62:35-45
39. Pohlmann AR, Weiss V, Mertins O, et al. Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: Development, stability evaluation and nanostructure models. Eur J Pharm Sci 2002;16:305-12
40. Raffin RP, Obach ES, Mezzalira G, et al. Nanoca'psulas polime'ricas secas contendo indometacina: Estudo de formulaça?o e de tolerância gastrintestinal em ratos. Acta Farm Bonaerense 2003;22(2):163-72 (Pubitemid 37022959)
41. Schaffazick SR, Pohlmann AR, Dalla-Costa T, et al. Freeze-drying polymeric colloidal suspensions: Nanocapsules, nanospheres and nanodispersion. A comparative study. Eur J Pharm Biopharm 2003;56:501-6
42. Pohlmann AR, Soares LU, Cruz L, et al. Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(e-caprolactone). Curr Drug Deliv 2004;1:103-10
43. Cruz L, Schaffazick SR, Dalla Costa T, et al. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. J Nanosci Nanotechnol 2006;6(9-10):3154-62 (Pubitemid 44579995)
44. Cruz L, Soares LU, Dalla Costa T, et al. Diffusion and mathematical modeling of release profiles from nanocarriers. Int J Pharm 2006;313:198-205
45. Weiss-Angeli V, Poletto FS, Zancan LR, et al. Nanocapsules of octyl methoxycinnamate containing quercetin delayed the photodegradation of both components under ultraviolet A radiation. J Biomed Nanotechnol 2008;4:80-9
46. Poletto FS, Ja?ger E, Cruz L, et al. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mater Sci Eng C 2008;28:472-8 (Pubitemid 351417799)
47. Pohlmann AR, Mezzalira G, Ventiruni CG, et al. Determining the simultaneous presence of drug nanocrystals in drug-loaded polymeric nanocapsule aqueous suspensions: A relation between light scattering and drug content. Int J Pharm 2008;359:288-93
48. Bernardi A, Frozza RL, Jager E, et al. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: An in vitro study. Eur J Pharmacol 2008;586:24-34
49. Cattani VB, Pohlmann AR, Dalla Costa T. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules. Int J Pharm 2008;363:214-16
50. Bernardi A, Braganhol E, Figueiró F, et al. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Lett 2009;281:53-63
51. Jager E, Venturini CG, Poletto FS, et al. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol 2009;5:130-40
52. Paese K, Jager A, Poletto FS, et al. Semisolid formulation containing a nanoencapsulated sunscreen: Effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol 2009;5(3):240-6
53. Haas SE, Bettoni CC, Oliveira LK, et al. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo. Int J Antimicrob Agents 2009;34:156-61
54. Cattani VB, Fiel LA, Jager A, et al. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs. Eur J Pharm Sci 2010;39:116-24
55. Frozza RL, Bernardi A, Paese K, et al. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J Biomed Nanotechnol 2010;6:694-703
56. Siqueira NM, Contri RV, Paese K, et al. Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules. Skin Pharmacol Physiol 2011;24:166-74
57. Jornada DS, Fiel LA, Bueno K, et al. Lipid-core nanocapsules: Mechanism of self-assembly, control of size and loading capacity. Soft Matter 2012;8:6646-55
58. Detoni CB, Souto GD, Silva ALM, et al. Photostability and skin penetration of different E-resveratrol-loaded supramolecular structures. Photochem Photobiol 2012;88(4):913-21
59. Silva ALM, Contri R, Jornada DS, et al. Vitamin K1-loaded lipid-core nanocapsules: physicochemical characterization and in vitro skin permeation. Skin Res Technol 2012;published online 7 June 2012; doi: 10.1111/j.1600-0846. 2012.00631.x
60. Guterres SS, Muller CR, Michalowski CB, et al. Gastro-intestinal tolerance following oral administration of spray-dried diclofenac-loaded nanocapsules and nanospheres. STP Pharm Sci 2001;11:229-33 (Pubitemid 32588267)
61. Alves MP, Scarrone AL, Santos M, et al. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007;341:215-20 (Pubitemid 47088101)
62. Flores FC, Ribeiro RF, Ourique AF, et al. Nanostructured systems containing an essential oil: protection against volatilization. Quim Nova 2011;34(6):968-72
63. Lenz QF, Guterres SS, Pohlmann AR, et al. Semi-solid topical formulations containing nimesulide-loaded nanocapsules showed in-vivo anti-inflammatory activity in chronic arthritis and fibrovascular tissue models. Inflamm Res 2012;61:305-10
64. Muller CR, Schaffazick SR, Pohlmann AR, et al. Spray-dried diclofenac-loaded poly(e-caprolactone) nanocapsules and nanospheres. Preparation and physicochemical characterization. Pharmazie 2001;56:864-7 (Pubitemid 33081720)
65. Ourique AF, Pohlmann AR, Guterres SS, et al. Tretinoin-loaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int J Pharm 2008;352:1-4
66. Friedrich RB, Fontana MC, Bastos MO, et al. drying polymeric drug-loaded nanocapsules: The wet granulation process as a promising approach. J Nanosci Nanotechnol 2010;10(1):616-21
67. Fiel LA, Rebêlo LM, Santiago TM, et al. Diverse deformation properties of polymeric nanocapsules and lipid-core nanocapsules. Soft Matter 2011;7:7240-7
68. Venturini CG, Jager E, Oliveira CP, et al. Formulation of lipid core nanocapsules. Colloid Surface A 2011;375:200-8
69. Almeida JS, Jezur L, Fontana MC, et al. Oil-based nanoparticles containing alternative vegetable oils (grape seed oil and almond kernel oil): preparation and characterization. Lat Am J Pharm 2009;28(2):165-72
70. Jime'nez MM, Pelletier J, Bobin MF, et al. Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int J Pharm 2004;272:45-55 (Pubitemid 38293010)
71. Guterres SS, Weiss V, Freitas LL, et al. Influence of benzyl benzoate as oil core on the physicochemical properties of spray-dried powders from polymeric nanocapsules containing indomethacin. Drug Deliv 2000;7:195-9 (Pubitemid 32057550)
72. Oliveira CP, Venturini CG, Donida B, et al. An algorithm to determine the mechanism of drug distribution in lipid-core nanocapsule formulations. Soft Matter 2013;9:1141-50
73. Fontana MC, Coradini K, Guterres SS, et al. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: Influence of the nanostructured system. J Biomed Nanotechnol 2009;5(3):254-63
74. Almeida JS, Lima F, Da Ros S, et al. Nanostructured systems containing rutin: In vitro antioxidant activity and photostability studies. Nanoscale Res Lett 2010;5:1603-10
75. Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20 (Pubitemid 32144788)
76. Fontana MC, Coradini K, Pohlmann AR, et al. Nanocapsules prepared from amorphous polyesters: Effect on the physicochemical characteristics, drug release and photostability. J Nanosci Nanotechnol 2010;10(5):3091-9
77. Marchiori ML, Lubini G, Dalla Nora G, et al. Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study. Drug Dev Ind Pharm 2010;36(8):962-71
78. Fontana MC, Rezer JFP, Coradini K, et al. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Eur J Pharm Biopharm 2011;79(2):241-9
79. Ourique A F, Azoubel S, Ferreira CV, et al. Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: Development and in vitro antitumor activity on human myeloid leukaemia cells. J Biomed Nanotechnol 2010;6:214-23
80. Ourique AF, Melero A, Silva CB, et al. Improved photostability and reduced skin permeation of tretinoin: Development of a semisolid nanomedicine. Eur J Pharm Biopharm 2011;79:95-101
81. Bettoni CC, Felippi CC, Andrade C, et al. Isotretinoin-loaded nanocapsules: Stability and cutaneous penetration by tape stripping in human and pig skin. J Biomed Nanotechnol 2012;8(2):258-71
82. Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2007;2:147-57
83. Joo HH, Kim JC, Lee HY, et al. Characterization and in vitro permeation study of poly(e-caprolactone) nanocapsules containing hinokitiol. J Disper Sci Technol 2008;29:492-5 (Pubitemid 351494110)
84. Joo HH, Lee HY, Guan YS, et al. Colloidal stability and in vitro permeation study of poly(e-caprolactone) nanocapsules containing hinokitiol. J Ind Eng Chem 2008;14:608-13
85. Bernardi A, Zilberstein ACCV, Jager E, et al. Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats. Br J Pharmacol 2009;158:1104-11
86. Bernardi A, Frozza RL, Horn AP, et al. Protective effects of indomethacin-loaded nanocapsules against oxygen-glucose de privation in organotypic hippocampal slice cultures: Involvement of neuroinflammation. Neurochem Int 2010;57:629-36
87. Bernardi A, Frozza RL, Meneghetti A, et al. Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Ab1-42 in Alzheimer's disease models. Int J Nanomedicine 2012;7:4927-42
88. Leite EA, Grabe-Guimaraes A, Guimaraes HN, et al. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsules devices. Life Sci 2001;80:1327-34
89. Poletto FS, Fiel LA, Lopes MV, et al. Fluorescent-labeled poly(e-caprolactone) lipid-core nanocapsules: Synthesis, physicochemical properties and macrophage uptake. J Colloid Sci Biotechnol 2012;1:89-98
90. Bulcao RP, Freitas FA, Venturini CG, et al. Acute and subchronic toxicity evaluation of poly(epsilon-caprolactone) lipid-core nanocapsules in rats. Toxicol Sci 2012;published online 12 Deceber 2012; doi; 10.1093/toxsci/kfs334
91. Guterres SS, Beck RCR, Pohlmann AR. Spray-drying technique to prepare innovative nanoparticulated formulations for drug administration: A brief overview. Braz J Phys 2009;39(1):205-9
92. Abdelwahed W, Degobert G, Stainmesse S, et al. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev 2006;58:1688-713 (Pubitemid 44827432)
93. Muller CR, Bassani VL, Pohlmann AR, et al. Preparation and characterization of spray-dried nanocapsules. Drug Dev Ind Pharm 2000;26:343-7
94. Beck RCR, Pohlmann AR, Guterres SS. Nanoparticle-coated microparticles: preparation and characterization. J Microencapsul 2004;21(5):499-512 (Pubitemid 39368977)
95. Muller CR, Hass SE, Bassani VL, et al. Degradaçao e estabilizaçao do diclofenado em nanoca'psulas polime'ricas. Quim Nova 2004;27(4):555-60
96. Terroso T, Kulkamp IC, Jornada DS, et al. Development of semi-solid cosmetic formulations containing Coenzyme Q10-loaded nanocapsules. Lat Am J Pharm 2009;28(6):819-26
97. Marchiori MCL, Ourique AF, Silva CB, et al. Spray-dried powders containing tretinoin-loaded engineered lipid-core nanocapsules: Development and photostability study. J Nanosci Nanotechnol 2011;12(3):2059-67
98. Friedrich RB, Bastos MO, Fontana MC, et al. Tablets containing drug-loaded polymeric nanocapsules: An innovative platform. J Nanosci Nanotechnol 2010;10(9):5885-8
99. Trierweiler LF, Trierweiler JO. Industrial production of polymeric nanoparticles: Alternatives and economic analysis. In: Beck RCR, Guterres SS, Pohlmann AR, editors, Nanocosmetics and nanomedicine, new approaches for skin care. Springer -Verlag; Berlin Heidelberg: 2011
100. Colombo AP, Briançon S, Lieto J, Fessi H. Project, design, and use of a pilot plant for nanocapsules production. Drug Dev Ind Pharm 2001;27(10):1063-72 (Pubitemid 34053202)